Established in 2011, Pathnostics is driven to pioneer a better future for physicians, patients, and the healthcare system with solutions that transform diagnostic and therapeutic dilemmas.
We cater to a number of different providers and care settings:
PRIMARY CARE PHYSICIANS
POST ACUTE CARE
IMMEDIATE CARE/URGENT CARE
HEALTHCARE AT HOME
Core capabilities in
infectious disease and cancer diagnostics
A CAP-accredited and CLIA-certified laboratory, Pathnostics drives forward patient care with its range of unique and advanced tests with a robust offering of histopathology, cytology, and molecular tests, including:
Pathnostics believes in robust science to demonstrate safety, efficacy, and clinical utility. To date, we have completed three (3) clinical studies involving more than 68,000 subjects for Guidance® UTI, our flagship platform that combines molecular detection with our proprietary Pooled Antibiotic Susceptibility Testing (P-AST™) technology. Key findings are published in six (6) peer-reviewed journals.
Pathnostics is not just a laboratory.
Our dedicated executive management team, Board of Directors, and Scientific Advisory Board aim to resolve diagnostic and therapeutic dilemmas through continuous research, clinical evidence development, product implementation, and service delivery.
LICENSES AND ACCREDITATIONS
News & Events
Pathnostics is rapidly growing and looking for dedicated individuals to join our team.
We value our employees as they are integral to the pioneering of groundbreaking solutions to guide effective therapy options. When you work at Pathnostics, you are a part of a greater purpose to improve the lives of patients every day.